510(k) · Cleared
ClearedGlucommander Plus
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Collaborativemed, LLC · NDC Calculator, Drug Dose
Cleared on Jun 7, 2006 as substantially equivalent to K040676 (Medtronic Minimed, 2004) and 5 other predicates after a 48-day review. Its family tree reaches back 6 generations to 1994. 1 of the 47 devices in its family, counting itself, has a Class I recall. 16 later devices descend from it.
- Decided
- Jun 7, 2006
- Review
- 48 days
- Class
- Class II
- Product code
- NDC
- Recalls
- None
- Predicates
- 6
Its longest line of descent runs back 6 generations to K941811 (1994). 30 ancestors in all, the oldest K822695 (1982). 16 later devices descend from it, 2 citing it directly. 1 of the 47 devices in this family, counting this one, has a Class I recall.
- Root · 6 generations backK941811 HP M1175A, M1176A, Component Monitoring SystemHewlett-Packard Co. · 1994
- 5 generations backK960934 HP M1205A Omnicare Component Monitor System Model 24Hewlett-Packard Co. · 1996
- 4 generations backK981376 Hewlett-Packard M1205A Viridia 24 CTHewlett-Packard Co. · 1999
- 3 generations backK990125 HP Viridia Component Monitoring System, Model Rev. KHewlett-Packard GmbH · 1999
- 2 generations backK992636 HP Carevue 9000 Clinical Information System, Model M2331AHewlett-Packard Co. · 1999 · Recalled
- 1 generation backK023674 Philips Drug Calculator SoftwarePhilips Medical Systems · 2002
- This deviceK061110 Glucommander PlusCollaborativemed, LLC · 2006
- Descendant · cites it directly · 13 of its ownK101344 G+ SystemGlytec, LLC (Formally Known AS Glucotec, Inc.) · 2010
- Descendant · 2 generations on · 12 of its ownK113853 G+ SystemGlytec, LLC · 2012
- Descendant · 3 generations on · 8 of its ownK132547 Endo Tool Glucose Management System (Egms)Monarch Medical Technologies · 2014 · Recalled
- Descendant · 4 generations on · 3 of its ownK200443 EndoTool IV 1.10Monarch Medical Technologies, LLC · 2020
- Descendant · 5 generations on · 2 of its ownK201619 EndoTool IV SystemMonarch Medical Technologies, LLC · 2020
Showing 5 of 16 descendants. See all descendants
Descendants cleared per year
Class I recalls in this family
- K042873 Animas Model IR1250 Insulin Infusion Pumpdirect predicate · 2004
Most influential descendants
Showing 5 of 16 · See all- K101344G+ SystemGlytec, LLC (Formally Known AS Glucotec, Inc.) · 2010 · cites it directly13descendants
- K113853G+ SystemGlytec, LLC · 2012 · 2 generations on12descendants
- K132547Endo Tool Glucose Management System (Egms)Monarch Medical Technologies · 2014 · 3 generations on8descendants
- K200443EndoTool IV 1.10Monarch Medical Technologies, LLC · 2020 · 4 generations on3descendants
- K201619EndoTool IV SystemMonarch Medical Technologies, LLC · 2020 · 5 generations on2descendants
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −6 | K941811 | HP M1175A, M1176A, Component Monitoring System | Hewlett-Packard Co. | 1994 | — |
| −5 | K960934 | HP M1205A Omnicare Component Monitor System Model 24 | Hewlett-Packard Co. | 1996 | — |
| −4 | K981376 | Hewlett-Packard M1205A Viridia 24 CT | Hewlett-Packard Co. | 1999 | — |
| −3 | K990125 | HP Viridia Component Monitoring System, Model Rev. K | Hewlett-Packard GmbH | 1999 | — |
| −2 | K992636 | HP Carevue 9000 Clinical Information System, Model M2331A | Hewlett-Packard Co. | 1999 | 8 |
| −1 | K023674 | Philips Drug Calculator Software | Philips Medical Systems | 2002 | — |
| 0 (this device) | K061110 | Glucommander Plus | Collaborativemed, LLC | 2006 | — |
| +1 | K101344 | G+ System | Glytec, LLC (Formally Known AS Glucotec, Inc.) | 2010 | — |
| +2 | K113853 | G+ System | Glytec, LLC | 2012 | — |
| +3 | K132547 | Endo Tool Glucose Management System (Egms) | Monarch Medical Technologies | 2014 | 1 |
| +4 | K200443 | EndoTool IV 1.10 | Monarch Medical Technologies, LLC | 2020 | — |
| +5 | K201619 | EndoTool IV System | Monarch Medical Technologies, LLC | 2020 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1982 | 1 | 0 |
| 1992 | 3 | 0 |
| 1993 | 1 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 1 | 0 |
| 1999 | 4 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 0 |
| 2004 | 3 | 1 |
| 2005 | 2 | 0 |
Descendants by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 2007 | 1 | 0 |
| 2008 | 1 | 0 |
| 2010 | 1 | 0 |
| 2012 | 1 | 0 |
| 2014 | 2 | 0 |
| 2015 | 1 | 0 |
| 2017 | 2 | 0 |
| 2018 | 1 | 0 |
| 2020 | 2 | 0 |
| 2021 | 1 | 0 |
| 2024 | 1 | 0 |
| 2026 | 2 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
1 device in this family has a Class I recall. A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new NDC device
- #1 K242775 InPen System App (MMT-8060 (iOS), MMT-8061…score 18.0 · 10 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (6)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K040676 | Medtronic Minimed Paradigm Insulin Pump, Models MMT-515 and MMT-715Summary page 1…lator, Class II Regulation Number: 868.1890 Device Class: Class II 4. Trade Name of Proposed Device: Glucommander Plus 5. Predicate Device: K040676, MiniMed Medtronic Paradigm Insulin Pump K042873, Animas Model IR1250 Insulin Infusion Pump K023674, Phillips Drug… | 2004 |
| * | K042873 | Animas Model IR1250 Insulin Infusion PumpSummary page 1…Device Class: Class II 4. Trade Name of Proposed Device: Glucommander Plus 5. Predicate Device: K040676, MiniMed Medtronic Paradigm Insulin Pump K042873, Animas Model IR1250 Insulin Infusion Pump K023674, Phillips Drug Calculator K043600, Medtronic MicroMed 407C… | 2004 |
| * | K023674 | Philips Drug Calculator SoftwareSummary page 1…: Glucommander Plus 5. Predicate Device: K040676, MiniMed Medtronic Paradigm Insulin Pump K042873, Animas Model IR1250 Insulin Infusion Pump K023674, Phillips Drug Calculator K043600, Medtronic MicroMed 407C K961486, IVAC MedSystem III, Infusion Pump w/ Drug Editi… | 2002 |
| * | K043600 | Medtronic Micromed 407C Infusion Pump, Model MMT-407CSummary page 1…Device: K040676, MiniMed Medtronic Paradigm Insulin Pump K042873, Animas Model IR1250 Insulin Infusion Pump K023674, Phillips Drug Calculator K043600, Medtronic MicroMed 407C K961486, IVAC MedSystem III, Infusion Pump w/ Drug Editing K051079, Hopira Gemstar Infusio… | 2005 |
| * | K961486 | Ivac Medsystem Iii, Infusion Pump W/Drug Editing Software KitSummary page 1…c Paradigm Insulin Pump K042873, Animas Model IR1250 Insulin Infusion Pump K023674, Phillips Drug Calculator K043600, Medtronic MicroMed 407C K961486, IVAC MedSystem III, Infusion Pump w/ Drug Editing K051079, Hopira Gemstar Infusion Pump System 6. Proposed Device Descri… | 1998 |
| * | K051079 | Hospira Gemstar Infusion Pump System with Hospira Gemstar Spring Assist Mechanism…Summary page 1…n Infusion Pump K023674, Phillips Drug Calculator K043600, Medtronic MicroMed 407C K961486, IVAC MedSystem III, Infusion Pump w/ Drug Editing K051079, Hopira Gemstar Infusion Pump System 6. Proposed Device Description: The Glucommander is a simple, automated, computer-based sof… | 2005 |
What descends from it? (16)
See all 162 later devices cite it directly; ranked here by how many devices descend from each in turn.
Has anything in its family been recalled? (1 Class I)
No FDA recall names this device.
Relatives with a Class I recall
Class I is FDA’s most serious recall class. A recall in the family tree is context for this device, not evidence about it.
- K042873Animas Model IR1250 Insulin Infusion PumpAnimas Corp. · 2004 · Direct predicate · ◆ in the 2004 ancestors bar of FIG. 11 Class I recall
What does this lineage say?
- The line of descent spans 12 years and passes through 4 companies; a new generation was cleared every 2.6 years on median.
- 6 of the 30 ancestors have a recall of any class; 1 has a Class I recall.
- Of its descendants, K101344 (Glytec, LLC (Formally Known AS Glucotec, Inc.), 2010) has gone furthest, with 13 descendants of its own.
- 1 other device also cites its predicate K040676.
How does its category compare?
All NDC devicesNDC Calculator, Drug Dose: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · NDC
2in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · NDC
60in 2024
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · NDC
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · NDC
299in 2025
MAUDE reports naming product code NDC, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 1 | — | 0 | 0 |
| 2008 | 2 | — | 0 | 7 |
| 2009 | 0 | — | 0 | 4 |
| 2010 | 1 | — | 0 | 18 |
| 2011 | 0 | — | 0 | 11 |
| 2012 | 2 | — | 0 | 2 |
| 2013 | 0 | — | 0 | 1 |
| 2014 | 3 | 118 | 0 | 1 |
| 2015 | 3 | 199 | 0 | 1 |
| 2016 | 2 | — | 1 | 18 |
| 2017 | 8 | 189 | 2 | 25 |
| 2018 | 3 | 220 | 1 | 21 |
| 2019 | 1 | — | 1 | 18 |
| 2020 | 5 | 53 | 0 | 10 |
| 2021 | 3 | 269 | 0 | 11 |
| 2022 | 0 | — | 1 | 347 |
| 2023 | 3 | 126 | 0 | 463 |
| 2024 | 3 | 60 | 0 | 168 |
| 2025 | 2 | — | 1 | 299 |
| 2026 | 4 | 90 | 2 | — |
What is it indicated for?
The Glucommander is intended to evaluate the current as well as cumulative patient blood glucose values, and, based on the aggregate of those measurements, whether one or many, calculate and recommend a dose of saline, glucose, and insulin to drive the blood glucose level, either up or down, towards a predetermined target range. Once that target blood glucose range has been reached, the system's function is to recommend dosing of insulin, glucose, and…
Read the full statement (203 words)
The Glucommander is intended to evaluate the current as well as cumulative patient blood glucose values, and, based on the aggregate of those measurements, whether one or many, calculate and recommend a dose of saline, glucose, and insulin to drive the blood glucose level, either up or down, towards a predetermined target range. Once that target blood glucose range has been reached, the system's function is to recommend dosing of insulin, glucose, and saline for the purpose of maintaining the patient's blood glucose level in that target range. The system is programmed to provide intravenous dosing of glucose, saline, and insulin; as well as subcutaneous dosing of glucose and insulin. The device is not intended for use with patients with known insulin allergies or patients under the age of 18.
The Glucommander's programmed logic is not a substitute for, but rather an assist to clinical reasoning. The measurements and calculations generated by the GBGDS are intended to be used by qualified and trained medical personnel in evaluating patient conditions in conjunction with clinical history, symptoms, and other diagnostic measurements, as well as the medical professional's clinical judgment. No medical decision should be based solely on the recommended guidance provided by this software program.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K061110 · printed Nov 6, 2026
Cite this page
510(k) Report. “K061110: Glucommander Plus.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K061110
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026